The volume overloading of the left ventricle which results from left to right (L-R) shunting through a ventricular septal defect (VSD) may be reduced by pharmacologic agents which lower systemic vascular resistance (R,) in excess of pulmonary arteriolar vascular resistance (R,). To study agents capable of decreasing the L-R shunt through systemic vasodilatation, we created a chronic lamb model with VSD and administered three vasodilators, prazosin (0.05 mg/kg), hydralazine (0.75 mg/kg), and minoxidil (0.25 mg/kg). Prazosin increased the R, while lowering R,, resulting in an increase in R,/R by 43% ( p Q 0.005). Prazosin decreased the pulmonary flow (Q,) slightly, decreased L-R shunt by 16%, reduced the pulmonary to systemic flow ratio Received July 25, 1983; accepted February 7, 1984 (QP/QS) b c 2 % ( p Q 0.005), and lowered the left atrial mean pressure (LA) by 16% ( p s 0.005) with no effect on heart rate.
Summary
The volume overloading of the left ventricle which results from left to right (L-R) shunting through a ventricular septal defect (VSD) may be reduced by pharmacologic agents which lower systemic vascular resistance (R,) in excess of pulmonary arteriolar vascular resistance (R,). To study agents capable of decreasing the L-R shunt through systemic vasodilatation, we created a chronic lamb model with VSD and administered three vasodilators, prazosin (0.05 mg/kg), hydralazine (0.75 mg/kg), and minoxidil (0.25 mg/kg). Prazosin increased the R, while lowering R,, resulting in an increase in R,/R by 43% ( p Q 0.005). Prazosin decreased the pulmonary flow (Q,) slightly, decreased L-R shunt by 16%, reduced the pulmonary to systemic flow ratio R, systemic vascular resistance L R , left to right Q JQ, ratios, pulmonary to systemic blood flow ratios Ao, mean aortic pressure
BSA, body surface area
The amount of left to right shunting found in the presence of a large VSD is determined largely by the ratio of R, to R,. Pharmacologic manipulation of these vascular beds may increase the Rpa/R, ratio and reduce interventricular shunting and volume overloading of the left ventricle. The mechanisms by which pulmonary arteriolar resistance is regulated in the presence of a left to right shunt at the ventricular level are unknown. These controlling mechanisms would appear to be important in determining the clinical course of patients with such defects and in optimizing their medical management. Studies with acute animal VSD models have suggested that vasodilators may decrease L-R shunting (28, 30) , although these studies may be limited by the use of acutely prepared, open chested animals. This study utilized a chronically instrumented lamb model of ventricular septal defect to evaluate the effects of three vasoactive agents in the awake, erect animal.
Ventricular septal defect is the most common congenital heart defect (13) and affected children may develop symptoms of congestive heart failure for which traditional management with digoxin and diuretics is often ineffective (29) . Surgical intervention in small, ill infants may have a higher mortality than if pharmacologic treatment allows the child to grow prior to operation (1 I). Additionally, effective pharmacologic treatment of these patients may allow the defect to become smaller or close spontaneously as the child grows (6, 14) .
We evaluated the effect of three clinically available vasodilators, prazosin, hydralazine, and minoxidil, on the hemodynamics found in a chronic lamb model of ventricular septal defect in order to determine if any of these agents showed vascular selectivity.
MATERIALS AND METHODS
Infant lambs (<2 weeks old) weighing 5 to 8 kg were anesthetized with 20 mg/kg of intramuscular ketamine. They were intubated and ventilated and a right thoracotomy was performed. The right atrial appendage was encircled with a purse-string suture and the lamb was given 2 mg/kg of intravenous lidocaine to prevent ventricular fibrillation when the grommet was inserted. A modification of the instrument described by Synhorst et al. (28) was used to pass a plastic grommet through the right atrial appendage, across the tricuspid valve, and near to the apex of the right ventricle. The tip of the instrument and the grommet were forced across the muscular interventricular septum. The instrument was removed and the grommet remained in the interventricular septum with the flanges on either end holding it in place. The internal diameter of the hole between the right and left ventricles was 8 mm which resulted in right ventricular systolic pressures which were approximately 50% of those in the left ventricle. The Q,/Q, ratios were routinely greater than 3: 1.
Approximately 1 week after the initial procedure, the lambs were again anesthetized and the ascending aorta and main pulmonary artery were exposed through a left thoracotomy. An electromagnetic flow probe (Biotronix, Inc.) of 12 mm internal diameter was placed around the ascending aorta and a probe of 14-16 mm was placed on the main pulmonary artery. Catheters were secured in the main pulmonary artery and left atrium and the proximal end of the catheters and the flow probe cables were tunneled subcutaneously to exit at the back of the neck. An aortic catheter was placed via the carotid artery and in several animals a right atrial catheter was placed via the internal jugular vein. Each of the catheters was filled with concentrated heparin. The flow probe connectors and stopcocks on the end of the left atrial pulmonary artery and aortic pressure lines which were exposed at the posterior base of the neck were wrapped carefully to prevent damage by the lamb. The lambs were allowed to recover for 1 week prior to the beginning of data collection.
Each flow probe was calibrated with saline, prior to implantation, on a blood vessel similar in size to the actual vessels over the range of flow expected for the animal. The implanted probes were periodically compared to Fick-determined estimates of the pulmonary to systemic flow ratio. Zero flow was determined for each data collection at end-diastole. A Biotronix 6 13 Drug administration. The drugs were infused via the pulmonary artery catheter over several minutes. On any given day, only one drug or sham infusion was given to a lamb. Prazosin was dissolved in distilled water with warming and the volume infused was always less than 2 ml. The dose of prazosin used for all animals was 0.05 mg/kg. Minoxidil was dissolved in a fashion similar to prazosin and given to the lambs in a dose of 0.25 mg/ kg. The drugs were weighed and prepared fresh on the day of use and were passed through a 0.45-p Millipore filter prior to use in order to sterilize the solutions. Hydralazine was given in a dose of 0.75 mg/kg and the intravenous preparation was obtained from the hospital pharmacy. The approximate dose for each drug was determined from published values (8, 10, 23) . The dose was then adjusted in initial studies in two l a m b t o produce the maximum reduction in R, without changing Ao.
Data collection. The lambs were studied while standing quietly in a supporting cradle. Control data were collected after a 30-min stabilization period and the lamb was then given either a drug infusion or a sham drug administration using a like volume of distilled water. Aortic, pulmonary artery, and left atrial pressures and phasic and mean aortic and pulmonary artery flows were recorded every 15 min. Heart rate was monitored continuously. "Cross-talk" between the flow probes was excluded since only one probe was energized at any given time. Six animals were included in each drug group. The lambs were 4-5 weeks of age at the time of data collection, were ambulatory, and were feeding normally. The hemoglobin values with this model ranged from 10-13 g/dl; the pH and arterial blood gases were within the normal range for this altitude (Poz 50-70 torr).
Data reduction. BSA was calculated using the formula BSA = 0.12 1 x (kg)2/3 (1 8). Flow and resistance data were indexed to body surface area. The data obtained immediately prior to drug administration were used as control values. T o eliminate differences in time of onset of action, the data obtained at the maximal reduction of systemic vascular resistance were used to compare the effect of one drug to another.
The L-R shunt was determined by subtracting the Q, from the Q,. The total pulmonary resistase .index (R,)was calculated according to the formula R, = PA/Q,, where PA is the mean pulmonary artery pressure. The total systemic resistance index (R,) was similarly calculated with the formula R, = Ao/Q,, where -Ao is the mean aortic pressure. Pulmonary arteriolar resistance (R,,) was calculated by subtracting the mean left atrial pressure (a) from the and dividing by the Q, according to the formula R,, = PA-LA/Q,. All resistance values were indexed to the BSA and are expressed without units.
Statistics. The data were evaluated for statistical significance using Student's t test for paired data since each animal served as its own control. Significant drug effect was defined as a change from control with a p value less than 0.05 (27) .
RESULTS

Stability of the model.
The mean values of data collected from six animals prior to and following sham drug administration are shown in Figure 1 . No significant change was observed in pressures, flows, or resistances over a 60-min period. The largest variation from control was an insignificant 6% decrease in the Qp/Q, ratio at 45 min.
Prazosin. The intravenously administered prazosin (0.05 mg/ kg) caused a reduction in R, which reached a maximum 22% less than control at 30 min. Increasing the dose of prazosin had no additional effect. At the time of maximal reduction of R,, R, was increased by 17%,resulting in an increase in R,/R, of 43% ( p s 0.005). The Qp/Q, ratio was reduced 22% (3.15 to 2.47; p s 0.01) as one would expect with an increase in R,/R, ratio (Table 1) . Q, increased by 0.6 liter/min/m2 (Fig. 2) . The left to right shunt volume (QL-R) was decreased from 5.8 to 4.8 liters/ min/m2 (16%; p s 0.01). The mean left atrial pressure was lowered from 16.0 to 13.4 mm Hg (16%; p s 0.005). The heart rate was not significantly altered by prazosin and a small reduction in both mean aortic and mean pulmonary artery pressure was seen (Table 2) .
Hydralazine. Hydralazine caused a significant decrease in R, but R, decreased also and the ratio Rpa/R, did not change significantly. Since both the pulmonary and systemic vascular beds were dilated, both the Qp and Q, were increased ( Fig. 3) . At the time of maximal effect (20 min), the Qp/Q, ratio was lowered 18% (3.54 versus 2.9 1; p s 0.005) due to a slightly greater effect on the R, compared to the R, and.the fixed resistance of the restrictive VSD itself (Table 1) (Table 2 ). In addition, a marked increase in heart rate from 162 to 200 ( p s 0.005) was seen. Increasing the d o 2 of hydralazine to 1.5 mg/kg caused a significant reduction in Ao and an increase in heart rate up to 240.
Minoxidil. Minoxidil (0.25 mg/kg) produced the greatest reduction in R, (41 %) but also reduced R, by 39% resulting in only a 17% increase in Rp,/R, ratio. The maximal effect on R, occurred at 45 min. The Qp/Q, ratio was lowered 26% but included increases in both Q, (9.8 to 1 1.8 liters/min/m2) and Q, (2.9 to 4.8 liters/min/m2) (Fig. 4) . The QL. R was unchanged (6.9 to 7.07 liters/min/m2). There were insignificant changes in mean left atrial, aortic, and pulmonary artery pressures. Heart rate increased from 156 to 206 (p 6 3 0 5 ) ( Table 2 ). Larger doses of minoxidil consistently lowered Ao and, like hydralazine, further increased the heart rate.
DISCUSSION
The ratio of pulmonary to systemic vascular resistance is important in determining the amount of left to right shunting which occurs in the presence of a large ventricular septa1 defect (14, 25, 28) . Pharmacologic agents which increase the ratio R, / R, may reduce L-R shunting and reduce the volume overload of the left ventricle which is found with VSD. The size of the VSD, and thus its inherent resistance, is also a major factor in controlling the L-R shunt. The larger the septal defect, the less is the resistance to flow, and thus the R, JR, ratio becomes the most significant factor. In this study, we used a chronic lamb model of VSD to study the effects of three pharmacologic agents with vasodilating properties. The ventricular septal defect was large enough to elevate left atrial pressure and allow changes in the R,/R, ratio to be reflected as a change in L-R shunt. The ventricular septal defect was, however, restrictive as demonstrated by peak pulmonary artery pressures being approximately 50-70% of aortic pressures. Creation of larger defects in our animals was associated with an intolerable acute mortality. Prazosin was found to cause a selective reduction of systemic vascular resistance which increased R,/R, and decreased QL-R. The pulmonary vascular bed is clearly responsive to a-adrenergic agonists (4, 22) and these agonists can be blocked by prazosin (7) . As the mechanism of action of prazosin involves competitive inhibition of a,-adrenergic receptors (5, 19), it appears that this type of receptor is not a major contributor to the elevated pulmonary arterial tone of lambs in the presence of a large left to right ventricular level shunt. It is possible that distension of the pulmonary arterial tree by the increased flow from the left to right shunt results in elevation of the pulmonary arteriolar vascular resistance in a manner described previously for ballooninduced distension of the pulmonary artery (16) . This reflex has been shown to be unaffected by a-adrenergic antagonists (1 5).
Additionally, a marked degree of pulmonary hypertension was produced in one subsequent lamb allowed to recover for 6 weeks after creation of the VSD and prior to instrumentation. This animal had systemic levels of pressure in the pulmonary artery and still showed the selective effect of prazosin on the systemic vascular bed (Fig. 5) . Thus, the mechanism of pulmonary hypertension, and not the absolute levels, appears to be important in the response to prazosin. The mild increase in R, with prazosin can be explained by a decrease in left atrial pressure and thus a decrease in the distention of the pulmonary vascular tree as proposed by Rudolph and Auld (26) . Since the left atrial pressure was lowered, the total pulmonary resistance was altered less than the pulmonary arteriolar resistance and the total pulmonary flow was decreased slightly. However, as a result of the systemic vasodilatation, there was a decrease in the L-R shunt volume and an increase in the forward flow from the left ventricle. Prazosin, by lowering left atrial pressure and decreasing L-R shunt volume, may decrease symptoms due to a restrictive ventricular septal defect although we cannot predict if this would be true for a larger nonrestrictive VSD. The reduction noted in left atrial pressure despite an insignificant reduction in pulmonary venous return is most likely due to the reduced afterload on the left ventricle. Prazosin is also a systemic venodilator (20) and this may contribute to the reduction of left atrial pressure. However, in three lambs the right atrial pressure was measured (mean of 8 mm Hg) and did not change significantly following prazosin (data not shown). Our observations support the previous findings of others describing the direct acting vasodilator hydralazine as a pulmonary vascular dilator (24) . Hydralazine did not alter the R,/R, ratio in our studies and the pulmonary flow, systemic flow, and L-R shunt volume all increased. The reduction of Q,/Q, in the absence of R,/R, change is likely due to the fixed resistance of the ventricular defect compared to the markedly reduced R,. The observed tachycardia is a known response to hydralazine. Minoxidil produced effects similar to hydralazine. Minoxidil and hydralazine did not change mean left atrial pressure significantly despite a decrease in left ventricular afterload, perhaps because both agents actually increased the volume of pulmonary venous return. There was no significant vascular selectivity of action by the direct acting agents and these agents were less efficacious than prazosin.
The reduction in R, following prazosin was less than that seen with either h@alazine or minoxidil, yet prazosin caused a small reduction in Ao. This was not anticipated from our preliminary studies and may relate to the lack of sympathetic overflow following vasodilatation with prazosin (12) .
The dose of each drug was comparable to previously published effective doses (8, 10, 23) . The dose was determined by titrating each agenGo the maximum fall in systemic resistance without changing Ao in two preliminary lambs. Prazosin showed a plateau in the dose-response curve since higher doses had no greater effect on R,. Larger doses of hydralazine or minoxidil caused2 further reduction in Rs but also caused sharp reductions in Ao (data not shown). The qualitative effects of these agents are not dose dependent (8, 10, 23) and there was no qualitative change following bolus administration in this study. Thus, it is unlikely that the observed pattern of response for each drug would be dose dependent.
Hydralazine is the only vasodilator studied in this project which has been investigated in patients with VSD. Beekman et al. (3) reported an increase in Q, and a decrease in QJQ, in infants with VSD studied in the catheterization laboratory. The effect of hydralazine was due to a decrease in R, despite no change in R, . However, Artman et al. (1) found that, when the pulmonary resistance was elevated in infants with atrioventricular canal defects, hydralazine caused pulmonary vasodilatation and thus did not change the L-R shunt. Nakazawa et al. (21) found that they could identify a subgroup of patients with VSD and low systemic resistance and hydralazine acted as a pulmonary vasodilator. The subgroup of patients with elevated systemic resistance did not show a pulmonary vasodilating response with hydralazine. In this study, hydralazine affected pulmonary and systemic vascular resistance similarly. The VSD in our study was restrictive as was the VSD in the clinical study of Nakazawa et al. (21) ; thus, the size of the VSD cannot explain the differing pattern of response to hydralazine. Several factors could explain these differences; our numbers may have been too small to identify varying patterns within subgroups and the pattern of response may vary with species. However, our data were gathered on awake nonsedated lambs. Nakazawa et al. did not specify the premedications given to their patients in the catheterization laboratory which may also affect the pattern of response. Linday et al. (1 7 ) did not demonstrate a beneficial effect of hydralazine on left to right shunts in patients of various ages and various cardiac sites of the shunt.
Whether the acute effects of prazosin seen in our study would be maintained with chronic use is unknown (2) . The only report of prazosin use in children with congestive failure did not show an attenuation of effect with time (9) . The effect of pharmacologic palliation of L-R shunts on possible subsequent development of pulmonary vascular occlusive disease is unknown. Our data do indicate that, in lambs with VSD, acute pharmacologic manipulation of shunt volume is feasible and of the agents studied prazosin was most effective.
these patients was associated with low plasma levels of Bcarotene and ceruloplasmin. These findings suggest that decreased serum copper levels may be associated with lipid and lipoprotein abnormalities and may enhance lipid peroxidation of LDL accounting for the color change. The increase in neutral lipids and the damaging effects on lipoprotein-transported substances may lead to atherosclerosis. Copper is an essential dietary component (13) and is known to be present in many plant and animal tissues (13) . Clinical evidence of deficiency was first observed in animals and many of the clinical manifestations have been related to low tissue activities of copper enzymes such as tyrosinase, lysyl oxidase, lactase, ascorbic acid oxidase, cytochrome oxidase, uricase, monoamine oxidase, and dopamine-P-hydroxylase (3 1). Clinical effects of copper deficiency are manifested as widespread derangements in tissues such as skin, bone, connective tissue, red blood cells and the central nervous system. In addition, increased tortuosity of arterial wall tissues may be attributed to defective
